BASEL, Switzerland, May 12, 2016 /PRNewswire/ -- Syngenta today announced the launch of the EPIVIO™ brand family, a range of new biostimulants which address abiotic stresses through seed treatment. Over the last five years Syngenta has developed abiotic stress management testing capabilities to simulate drought, heat, cold and nutrient stresses. Seed treatment products resulting from this R&D platform are now commercialized under the EPIVIO™ brand in combination with other Seedcare products to improve plant growth while addressing difficult-to-control pathogens, insects and nematodes.
EPIVIO™ products stimulate seedling development by providing micronutrients and biostimulant compounds to the plant and by activating soil microflora. The resulting natural symbiotic cycle leads to stress tolerant plants. Extensive field trials in Latin America have demonstrated yield benefits averaging 5% to soybean growers under a broad range of conditions.
Ioana Tudor, Syngenta Global Head of Seedcare, said "Syngenta has always been at the forefront in delivering innovation through seed applied fungicides, insecticides and nematicides – as well as through our focus on root health. We see soil productivity as a major new opportunity to make crops more efficient, stress tolerant and higher yielding"
First sales of EPIVIO™ will take place this year in Brazil for soybean and in China for corn. EPIVIO™ will then be rapidly expanded to additional crops and geographies.
Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com. Follow us on Twitter® at www.twitter.com/Syngenta.
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.
Syngenta International AG
Tel: +41 61 323 2323
Fax: +41 61 323 2424
Switzerland +41 61 323 2323
USA +1 202 737 8913
Switzerland +41 61 323 5059
USA +1 202 737 6521
Switzerland +41 61 323 1910
USA +1 202 737 6520
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/syngenta-launches-new-biological-seed-treatment-300267467.html
SOURCE Syngenta International AG